BioLineRx Falls Most in 2 Weeks, Narrows Gap With U.S. Stock

BioLineRx Ltd. slid the most in almost two weeks, narrowing the gap with the biophamaceutical company’s American depositary receipts.

The shares slumped 11 percent, the most since Jan. 26, to 1.66 shekels, or the equivalent of 45 cents, at the 4:30 p.m. close in Tel Aviv. The company’s ADRs, each representing 10 shares, closed at $4.44 yesterday in New York.

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.